Dr. Reddy's Laboratories Ltd Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while StoneX Group Inc. Common Stock trades at $59.51 (market cap $7.27B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while StoneX Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| RDY | SNEX | |
|---|---|---|
Market Cap | $10.78B | $7.27B |
Volume | 2,724,343 | 1,624,795 |
Sector | Health | Financials |
52-Week High | $15.38 | $92.67 |
52-Week Low | $11.38 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $28.28B |
Dividend Yield | 0.65% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →